Specialist Updates 
Respiratory

Is nasal high-flow therapy of value in hypercapnic COPD?

Trial pits the device against non-invasive ventilation
Medicom Staff writer
0
11 September 2020
Save
Please login to bookmark Close

AusDoc brings you the latest news from the European Respiratory Society Congress 2020.

Patients with chronic hypercapnic COPD who reject non-invasive ventilation might do as well with nasal high-flow therapy, a study suggests.

The new approach to oxygen delivery might be especially useful for patients who will not tolerate a face mask, the authors say.

German researchers presented the results of a study of 102 patients with the condition to the European Respiratory Society’s 2020 (ERS 2020) international virtual congress.

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Content that breaches the privacy of other individuals
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .